Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
2018 · The Lancet HIV · 121 citations
https://doi.org/10.1016/s2352-3018(18)30071-7
Z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
6.7K
Citations
34
h-index
57
i10-index
Zoe Moodie is an academic researcher from Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa. The author has contributed to research in topics: HIV Research and Treatment & vaccines and immunoinformatics approaches & HIV/AIDS Research and Interventions. The author has an h-index of 34, co-authored 92 publications.
ORCID: 0000-0001-8701-2001Papers by this author
worksHormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial
2020 · Nature Communications · 55 citations
https://doi.org/10.1038/s41467-020-19382-9
Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error
2012 · Statistics in Medicine · 12 citations
https://doi.org/10.1002/sim.5446
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
2021 · Human Immunology · 9 citations
https://doi.org/10.1016/j.humimm.2021.09.006
Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies
2024 · Cell Reports · 7 citations
https://doi.org/10.1016/j.celrep.2024.114811
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702
2024 · Vaccine · 1 citations
https://doi.org/10.1016/j.vaccine.2024.05.039
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat